Ensuring Precision in Dose Accuracy Verification
Today's Clinical Lab
Solutions for mitigating error and improving precision in dose accuracy testing
Drug Therapy
Selective PARP Inhibitor Improves Survival in Breast Cancer Trial
American Association for Cancer Research
Saruparib has higher selectivity for PARP1, improving safety and tolerability compared to existing first-gen PARP inhibitors
New Drug Slows Rare, Debilitating Genetic Disease in Trials
National Institutes of Health
The NIH-supported clinical trial could lead to the first effective treatment for ACDC disease
PARP Inhibitor Delays Uterine Cancer Recurrence in Phase 2 Trial
University of Colorado Anschutz Medical Campus
There are currently no approved maintenance therapies for metastatic and recurrent uterine/endometrial cancer
mAb Combo Therapy Safe to Treat Advanced Cancers
Wiley
CS1002 plus CS1003 showed promising antitumor activity and had a manageable safety profile across a broad dosing range in trials
Arginine Starvation Abates Rare Lung Cancer
Queen Mary University of London
The treatment significantly increases the survival of people with malignant mesothelioma, according to results from Phase 3 trial
mAb–Drug Therapy Combo Improves NSC Lung Cancer
University of Texas MD Anderson Cancer Center
Phase 2 trial finds durvalumab–ceralasertib boosted immune response and improved outcomes in patients with lung cancer
Androgen Receptor Modulator Drug Could Improve Breast Cancer
University of Liverpool
Phase 2 trial results indicate benefits of the new way of treating advanced ER+ breast cancer
Combination Hormone Therapy May Delay Cancer Progression
University of California - San Francisco
Prostate cancer affects 1 in 8 men and causes 34,000 deaths each year in the US
Comprehensive Analysis Reveals 370 Novel Anticancer Drug Targets
Wellcome Trust Sanger Institute
Second generation of the Cancer Dependency Map uncovers priority drug targets with strong links to specific cancer types